Jupiter Neurosciences

(NASDAQ) JUNS

Current Price$0.22

Market Cap$10.07M

Since IPO (2024)-96%

5 YearN/A

1 Year-74%

1 Month-30%

Jupiter Neurosciences Financials at a Glance

Market Cap

$10.07M

Revenue (TTM)

$40.45K

Net Income (TTM)

-$9.18M

EPS (TTM)

-$0.27

P/E Ratio

-0.86

Dividend

$0.00

Beta (Volatility)

0.29 (Low)

Dividend

$0.00

Beta (Volatility)

0.29 (Low)

Price

$0.22

Volume

1,756,238.655

Open

$0.22

Price

$0.22

Volume

1,756,238.655

Open

$0.22

Previous Close

$0.23

Daily Range

$0.21 - $0.23

52-Week Range

$0.17 - $3.33

Estimated Earnings Date

Sep 2, 2026

Dividend

$0.00

Beta (Volatility)

0.29 (Low)

Price

$0.22

Volume

1,756,238.655

Open

$0.22

Previous Close

$0.23

Daily Range

$0.21 - $0.23

52-Week Range

$0.17 - $3.33

Estimated Earnings Date

Sep 2, 2026

JUNS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Jupiter Neurosciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Christer Rosén

Website

www.jupiterneurosciences.com

Headquarters

Jupiter, FL 33477, US

JUNS Financials

Key Financial Metrics (TTM)

Gross Margin

89%

Operating Margin

-231%

Net Income Margin

-227%

Return on Equity

-6529%

Return on Capital

Return on Assets

-2%

Earnings Yield

-1.16%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$10.07M

Shares Outstanding

43.42M

Volume

1.76M

Avg. Volume

5.89M

Financials (TTM)

Gross Profit

$17.57K

Operating Income

-$8.91M

EBITDA

-$8.58M

Operating Cash Flow

-$5.41M

Capital Expenditure

-$4.00

Free Cash Flow

-$5.41M

Cash & ST Invst.

$3.79M

Total Debt

$5.32M

Jupiter Neurosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$18.65K

N/A

Gross Profit

$14.29K

N/A

Gross Margin

76.61%

N/A

Market Cap

$10.07M

N/A

Market Cap/Employee

$2.52M

N/A

Employees

N/A

Net Income

-$2.06M

-34.9%

EBITDA

-$1.96M

-28.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$2.36M

-12.7%

Total Debt

$4.83M

+2251.8%

Accounts Receivable

$0.00

N/A

Inventory

$148.07K

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$4.83M

+2353.4%

Return on Assets

-2.32%

N/A

Return on Invested Capital

3.35%

N/A

Free Cash Flow

-$1.43M

-34.7%

Operating Cash Flow

-$1.43M

-34.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ABVCABVC BioPharma, Inc.

ABVCABVC BioPharma, Inc.$1.31-0.76%

SKYESkye Bioscience, Inc.

SKYESkye Bioscience, Inc.$0.77+2.05%

GNTAGenenta Science S.p.A.

GNTAGenenta Science S.p.A.$1.64+2.35%

ALGSAligos Therapeutics, Inc.

ALGSAligos Therapeutics, Inc.$5.13-0.19%

GRCEGrace Therapeutics, Inc.

GRCEGrace Therapeutics, Inc.$2.29-1.72%

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

KZRKezar Life Sciences, Inc.

KZRKezar Life Sciences, Inc.$7.29+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$44.65+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.20+0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.14-0.07%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.42+0.00%

HOODRobinhood Markets

HOODRobinhood Markets$88.49+0.06%

MARAMara Holdings

MARAMara Holdings$12.80-0.04%

NVDANvidia

NVDANvidia$201.21-0.03%

Questions About JUNS

What is the current price of Jupiter Neurosciences?

Jupiter Neurosciences is trading at $0.22 per share.

What is the 52-week range for Jupiter Neurosciences?

Over the past 52 weeks, Jupiter Neurosciences has traded between $0.17 and $3.33.

How much debt does Jupiter Neurosciences have?

As of the most recent reporting period, Jupiter Neurosciences reported total debt of $4.86M.

How much cash does Jupiter Neurosciences have on hand?

Jupiter Neurosciences reported $2.36M in cash and cash equivalents in its most recent financial results.

What is Jupiter Neurosciences’s dividend yield?

Jupiter Neurosciences does not currently have a dividend yield.

Jupiter Neurosciences

Jupiter Neurosciences Financials at a Glance

JUNS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Jupiter Neurosciences

JUNS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Jupiter Neurosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About JUNS

What is the current price of Jupiter Neurosciences?

What is the 52-week range for Jupiter Neurosciences?

How much debt does Jupiter Neurosciences have?

How much cash does Jupiter Neurosciences have on hand?

What is Jupiter Neurosciences’s dividend yield?

Premium Investing Services